Howard S. Hochster, MD of Yale School of Medicine discusses the importance of recommending molecular testing early on to patients with colon cancer. He further explains the significance of HER2 testing in colon cancer. This was recorded at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
Importance of Early Molecular Testing in Colon Cancer
